Table 3.

Secondary Outcomes for Primary Total Hip and Knee Arthroplasty

THA	IV TXA (n = 108)	Topical TXA (n = 48)	P
Complication, n (%)
Wound drainage	8 (7%)	1 (2%)	.151
Deep vein thrombosis	0	1 (2%)	.124
Pulmonary embolism	0	0	—
Cardiac eventa	0	3 (6%)	.007
Cerebrovascular event	0	1 (2%)	.124
Mean (SD) length of stay, d	2.7 (1.59)	2.6 (1.67)	.889
TKA	IV TXA (n = 83)	Topical TXA (n = 52)	P
Complication, n (%)
Wound drainage	7 (8%)	2 (4%)	.281
Deep vein thrombosis	3 (4%)	0	.085
Pulmonary embolism	0	1 (2%)	.166
Cardiac event	0	1 (2%)	.166
Cerebrovascular event	1 (2%)	0	.322
Mean (SD) length of stay, d	2.3 (1.23)	3.2 (6.42)	.248

Abbreviations: IV, intravenous; THA, total hip arthroplasty; TKA, total knee arthroplasty; TXA, tranexamic acid.

^aSignificant difference.